The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin Resistance | MicrobiomeTrials← Back to trialsNCT07514364
The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin Resistance
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-01-01Est. Completion: 2026-03-01
Enrollment target: 60 participants Locations- National Taiwan University Hospital, Taipei, Taiwan
Other microbiome trials you might be interested in
Mycobacterium Infections
This study will examine the symptoms, course of disease and treatment of non-tuberculous mycobacterial (NTM) infections,…
Bethesda, United States
Non-Tuberculous Mycobacterial (NTM) PneumoniaMycobacterium Abscessus Infection
This study aims to use mycobacteriophage therapy, using identified in-vitro effective Mycobacteriophage Muddy\_HRMN0052,…
Vancouver, CanadaCompleted Oct 2027